ADmit Therapeutics

Developer of a medical diagnostic test designed for the early detection of Alzheimer's disease. The company's diagnostic test is based on an epigenetic analysis in blood samples that covers methylcyto...

Healthcare
Barcelona, Spain
Founded 2017
10 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$37.5M
Last Round
N/A

Get the full picture

Create a free account to unlock ADmit Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required